AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
2021 · Cell Research · 498 citations
https://doi.org/10.1038/s41422-020-00460-y
L
Lu Lu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
453
Papers
20.3K
Citations
64
h-index
268
i10-index
Lu Lu is an academic researcher from University of Science and Technology. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & HIV Research and Treatment & HIV/AIDS drug development and treatment. The author has an h-index of 64, co-authored 386 publications.
ORCID: 0000-0002-2255-0391Papers by this author
worksThe role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
2020 · Signal Transduction and Targeted Therapy · 363 citations
https://doi.org/10.1038/s41392-020-0184-0
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
2020 · Signal Transduction and Targeted Therapy · 205 citations
https://doi.org/10.1038/s41392-020-00402-5
RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
2020 · Cellular and Molecular Immunology · 172 citations
https://doi.org/10.1038/s41423-020-0424-9
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
2022 · Signal Transduction and Targeted Therapy · 172 citations
https://doi.org/10.1038/s41392-022-01105-9
The combination of PD-1 blockade with interferon-α has a synergistic effect on hepatocellular carcinoma
2022 · Cellular and Molecular Immunology · 125 citations
https://doi.org/10.1038/s41423-022-00848-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat